Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
Health Technology » Pharmaceuticals Other
|HZNP||Horizon Therapeutics Plc||2.25%||93.51||5.5%||$179.67m|
|VRX||Valeant Pharmaceuticals International, Inc.||0.13%||30.30||14.1%||$178.29m|
|GWPH||GW Pharmaceuticals Plc||0.21%||218.81||6.1%||$124.34m|
|BHC||Bausch Health Cos., Inc.||0.13%||30.30||0.0%||$108.60m|
|UTHR||United Therapeutics Corp.||-0.55%||201.67||14.1%||$97.68m|
|JAZZ||Jazz Pharmaceuticals Plc||1.21%||168.39||2.3%||$90.22m|
|SAVA||Cassava Sciences, Inc.||-1.63%||35.09||0.0%||$67.46m|
|PRGO||Perrigo Co. Plc||1.94%||41.17||6.9%||$37.55m|
|SAGE||SAGE Therapeutics, Inc.||-0.23%||75.50||7.6%||$37.53m|
|AMRN||Amarin Corp. Plc||-1.96%||5.01||1.5%||$29.35m|
|PCRX||Pacira Biosciences, Inc.||-4.45%||66.34||9.9%||$27.57m|
|ICPT||Intercept Pharmaceuticals, Inc.||-4.02%||20.55||16.8%||$22.11m|
Amarin Corp. Plc is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. Its product development program leverages its experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. It has developed and markets Vascepa capsules through wholesale. The company was founded by Geoffrey W. Guy on March 1, 1989 and is headquartered in Dublin, Ireland.